Bioventus Inc. (BVS) Financials

BVS Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 650.5 million 416.3 million
Dec. 31, 2025 683.6 million 455.1 million
Sept. 30, 2025 701.6 million 494.3 million
June 30, 2025 706.8 million 505.5 million

BVS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 8.4 million 3.3 million
Dec. 31, 2025 37.4 million 3.4 million
Sept. 30, 2025 29.6 million 3.2 million
June 30, 2025 25.3 million 3.6 million

BVS Net Income

No data available :(

BVS Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 35.8 million - -
Dec. 31, 2025 51.2 million 279.0 million 13.2 million
Sept. 30, 2025 42.2 million 311.3 million -
June 30, 2025 32.9 million 297.9 million -

BVS Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 70.0 million
Dec. 31, 2025 68.9 million
Sept. 30, 2025 68.8 million
June 30, 2025 68.5 million

BVS Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 574000 2.5 million 78.3 million -
Dec. 31, 2025 580000 3.0 million 82.8 million -
Sept. 30, 2025 473000 2.9 million 77.8 million -
June 30, 2025 683000 3.2 million 79.1 million -

BVS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 132.1 million 42.4 million
Dec. 31, 2025 157.9 million 53.4 million
Sept. 30, 2025 138.7 million 45.8 million
June 30, 2025 147.7 million 45.6 million

BVS Revenue by Segment
Graph available only for paid members. Upgrade to see it.

BVS

Price: $11.80

52 week price:
5.81
12.43

Payout Ratio Range:
-157.39%
216.97%

Earnings Per Share: 0.41 USD

P/E Ratio: 24.85

Exchange: NMS

Sector: Healthcare

Industry: Medical Devices

Market Capitalization: 710.0 million

Links: